Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer
-
Published:2024-10
Issue:10
Volume:35
Page:902-913
-
ISSN:0923-7534
-
Container-title:Annals of Oncology
-
language:en
-
Short-container-title:Annals of Oncology
Author:
Di Federico A.ORCID,
Alden S.L.ORCID,
Smithy J.W.ORCID,
Ricciuti B.,
Alessi J.V.,
Wang X.,
Pecci F.,
Lamberti G.,
Gandhi M.M.,
Vaz V.R.ORCID,
Spurr L.F.,
Sholl L.M.ORCID,
Pfaff K.L.,
Rodig S.J.,
Li Y.Y.,
Cherniack A.D.,
Nishino M.,
Johnson B.E.ORCID,
Awad M.M.ORCID